These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience. Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993 [TBL] [Abstract][Full Text] [Related]
3. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients. Kim JH; Schaenman JM; Ho DY; Brown JM Biol Blood Marrow Transplant; 2011 Feb; 17(2):259-64. PubMed ID: 20615475 [TBL] [Abstract][Full Text] [Related]
4. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir]. Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981 [TBL] [Abstract][Full Text] [Related]
5. A new topical treatment for resistant herpes simplex infections. Snoeck R; Andrei G; De Clercq E; Gerard M; Clumeck N; Tricot G; Sadzot-Delvaux C N Engl J Med; 1993 Sep; 329(13):968-9. PubMed ID: 8395657 [No Abstract] [Full Text] [Related]
6. Diagnostic methods and management strategies of herpes simplex and herpes zoster infections. Frisch S; Guo AM Clin Geriatr Med; 2013 May; 29(2):501-26. PubMed ID: 23571042 [TBL] [Abstract][Full Text] [Related]
7. Antiviral drug reduces shedding of herpes virus. Newsline People AIDS Coalit N Y; 1998 Feb; ():36. PubMed ID: 11367447 [TBL] [Abstract][Full Text] [Related]
8. Management of multidrug-resistant viruses in the immunocompromised host. Sellar RS; Peggs KS Br J Haematol; 2012 Mar; 156(5):559-72. PubMed ID: 22188225 [TBL] [Abstract][Full Text] [Related]
9. Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS. Smith NA; Wood C; Asboe D; Bingham JS AIDS; 1997 Feb; 11(2):254-5. PubMed ID: 9030377 [No Abstract] [Full Text] [Related]
10. Use of therapeutic drug monitoring in the long-term valaciclovir therapy of relapsing herpes simplex virus encephalitis in children. Lim M; Menson E; Tong CY; Lin JP J Antimicrob Chemother; 2009 Dec; 64(6):1340-1. PubMed ID: 19828489 [No Abstract] [Full Text] [Related]
11. Predictors and outcomes of acyclovir-resistant herpes simplex virus infection among hematopoietic cell transplant recipients: case-case-control investigation. Patel D; Marchaim D; Marcus G; Gayathri R; Lephart PR; Lazarovitch T; Zaidenstein R; Chandrasekar P Clin Transplant; 2014 Jan; 28(1):1-5. PubMed ID: 24033498 [No Abstract] [Full Text] [Related]
14. [Biological effects of coordinated compounds of transitional metals. 7. Antiviral activity of 4-methyl-2-aminopyridine palladium chloride against herpes simplex virus type 1 and type 2 in vitro and in vivo]. Wutzler P; Thiel KD; Tonew M; Tonew E; Schröer HP; Stelzner A Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Oct; 266(3-4):563-6. PubMed ID: 2830739 [TBL] [Abstract][Full Text] [Related]
15. Resistance to antivirals. Laufer DS; Starr SE Pediatr Clin North Am; 1995 Jun; 42(3):583-99. PubMed ID: 7761142 [TBL] [Abstract][Full Text] [Related]
16. [Herpes diseases in pregnant patients and newborn infants. Prognosis and therapy of intrauterine and neonatal herpes simplex virus diseases]. Peuckert W Klin Padiatr; 1988; 200(6):471-3. PubMed ID: 2853248 [No Abstract] [Full Text] [Related]
17. [Effect of desoxyribonuclease on herpes simplex virus]. Kossak NI Mikrobiol Zh; 1967; 29(4):312-6. PubMed ID: 4310245 [No Abstract] [Full Text] [Related]
18. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome. Chatis PA; Miller CH; Schrager LE; Crumpacker CS N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137 [No Abstract] [Full Text] [Related]